Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 22735596)

1.

Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.

Sugihara Y, Taniguchi H, Kushima R, Tsuda H, Kubota D, Ichikawa H, Sakamoto K, Nakamura Y, Tomonaga T, Fujita S, Kondo T.

J Proteomics. 2012 Sep 18;75(17):5342-55. doi: 10.1016/j.jprot.2012.06.013. Epub 2012 Jun 24.

PMID:
22735596
2.

An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.

Han CL, Chen JS, Chan EC, Wu CP, Yu KH, Chen KT, Tsou CC, Tsai CF, Chien CW, Kuo YB, Lin PY, Yu JS, Hsueh C, Chen MC, Chan CC, Chang YS, Chen YJ.

Mol Cell Proteomics. 2011 Apr;10(4):M110.003087. doi: 10.1074/mcp.M110.003087. Epub 2011 Jan 5.

3.

Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.

Chen D, Chen F, Lu X, Yang X, Xu Z, Pan J, Huang Y, Lin H, Chi P.

Int J Oncol. 2010 Aug;37(2):355-65.

PMID:
20596663
4.

Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.

Zheng P, Liu YX, Chen L, Liu XH, Xiao ZQ, Zhao L, Li GQ, Zhou J, Ding YQ, Li JM.

J Proteome Res. 2010 Oct 1;9(10):4897-905. doi: 10.1021/pr100712t.

PMID:
20806969
5.

Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.

Ma Y, Zhao M, Zhong J, Shi L, Luo Q, Liu J, Wang J, Yuan X, Huang C.

J Cell Biochem. 2010 Aug 15;110(6):1512-9. doi: 10.1002/jcb.22726.

PMID:
20524204
6.

Survivin expression in colorectal adenocarcinoma using tissue microarray.

Abd El-Hameed A.

J Egypt Natl Canc Inst. 2005 Mar;17(1):42-50.

7.

Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.

Tan HT, Wu W, Ng YZ, Zhang X, Yan B, Ong CW, Tan S, Salto-Tellez M, Hooi SC, Chung MC.

J Proteome Res. 2012 Feb 3;11(2):1433-45. doi: 10.1021/pr2010956. Epub 2012 Jan 10.

PMID:
22181002
8.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J, Zeng L, Fan J, Li X, Gong Y, Shen H.

J Proteome Res. 2007 Jul;6(7):2495-501. Epub 2007 Jun 2.

PMID:
17542627
9.

Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers.

Jaïs P, Sabourin JC, Bombled J, Rougier P, Lasser P, Duvillard P, Bénard J, Bressac-de Paillerets B.

Br J Cancer. 1998 Nov;78(10):1356-60.

10.

Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.

Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, Shen T, Zhou Y, Chen H, Chu Z, Zhang M, Qin H.

Mol Cell Proteomics. 2009 Aug;8(8):1878-90. doi: 10.1074/mcp.M800541-MCP200. Epub 2009 May 20.

11.

Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.

Orimo T, Ojima H, Hiraoka N, Saito S, Kosuge T, Kakisaka T, Yokoo H, Nakanishi K, Kamiyama T, Todo S, Hirohashi S, Kondo T.

Hepatology. 2008 Dec;48(6):1851-63. doi: 10.1002/hep.22552.

PMID:
18937283
12.

End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis.

Stypula-Cyrus Y, Mutyal NN, Dela Cruz M, Kunte DP, Radosevich AJ, Wali R, Roy HK, Backman V.

FEBS Lett. 2014 Mar 3;588(5):829-35. doi: 10.1016/j.febslet.2014.01.046. Epub 2014 Feb 1.

13.

Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.

Zhang J, Song MQ, Zhu JS, Zhou Z, Xu ZP, Chen WX, Chen NW.

Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):849-59.

PMID:
22230392
14.

MTSS1 overexpression correlates with poor prognosis in colorectal cancer.

Wang D, Xu MR, Wang T, Li T, Zhu Jw.

J Gastrointest Surg. 2011 Jul;15(7):1205-12. doi: 10.1007/s11605-011-1546-2. Epub 2011 May 12.

PMID:
21562916
15.

Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.

Zhao L, Liu L, Wang S, Zhang YF, Yu L, Ding YQ.

J Cancer Res Clin Oncol. 2007 Oct;133(10):771-82. Epub 2007 May 15.

PMID:
17503081
16.

A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.

Peng J, Zhang Q, Ma Y, Wang Y, Huang L, Zhang P, Chen J, Qin H.

Electrophoresis. 2009 Sep;30(17):2976-87. doi: 10.1002/elps.200900203.

PMID:
19711377
17.

Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.

Ma YL, Peng JY, Zhang P, Huang L, Liu WJ, Shen TY, Chen HQ, Zhou YK, Zhang M, Chu ZX, Qin HL.

J Proteome Res. 2009 Oct;8(10):4525-35. doi: 10.1021/pr900365e.

PMID:
19715280
18.

Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer.

Lin BR, Chang CC, Chen RJ, Jeng YM, Liang JT, Lee PH, Chang KJ, Kuo ML.

Clin Cancer Res. 2011 May 15;17(10):3077-88. doi: 10.1158/1078-0432.CCR-09-3256. Epub 2011 May 10.

19.

The APC-EB1 interaction.

Morrison EE.

Adv Exp Med Biol. 2009;656:41-50. Review.

PMID:
19928351
20.

Regulation and function of the interaction between the APC tumour suppressor protein and EB1.

Askham JM, Moncur P, Markham AF, Morrison EE.

Oncogene. 2000 Apr 6;19(15):1950-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk